The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
The Growing Genetic and Functional Diversity of Extended Spectrum Beta-Lactamases
Open accessAbstract
The β-lactams—a large class of diverse compounds—due to their excellent safety profile and broad antimicrobial spectrum are considered to be the most widely used therapeutic class of antibacterials prescribed in human and veterinary clinical practices. This, unfortunately, has also given rise to a continuous increased resistance globally in health care settings as well as in the community due to their permanent selective force driving diversification of the resistance mechanism. Resistance against β-lactams is increasing rapidly as novel β-lactamases, enzymes that degrade β-lactams, are being discovered each day such as recent emergence of extended spectrum β-lactamases (ESBL) that have the ability to inactivate most of the cephalosporins. The complexity and diversity of ESBL are increasing so rapidly that more than 170 variants have thus far been described for only a single genotype, theblaCTX-M-encoding ESBL. This review is to organize all the current updated literature describing genomic features, organization, and mechanism of resistance and mode of dissemination of all known ESBLs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
The International IBD Genetics Consortium (IIBDGC), Jostins, L., Ripke, S., Weersma, R. K., Duerr, R. H., McGovern, D. P., Hui, K. Y., Lee, J. C., Philip Schumm, L., Sharma, Y., et al. (2012) · Nature · doi:10.1038/nature11582 · Cited by 4,722
Updated Functional Classification of β-Lactamases
Bush, K., & Jacoby, G. A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01009-09 · Cited by 2,367 · cited 2×
“ESBLs are often found carried on large plasmids in addition to other resistance genes that confer resistance to antimicrobials such as aminoglycosides and sulphonamides [56].”
BackgroundJacoby, G. A. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00036-08 · Cited by 2,165
Outer membrane permeability and antibiotic resistance
Delcour, A. H. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2008.11.005 · Cited by 1,762
An Enzyme from Bacteria able to Destroy Penicillin
ABRAHAM, E. P., & CHAIN, E. (1940) · Nature · doi:10.1038/146837a0 · Cited by 1,333
The CTX-M β-lactamase pandemic
Cantón, R., & Coque, T. M. (2006) · Current Opinion in Microbiology · doi:10.1016/j.mib.2006.08.011 · Cited by 1,147
Integrons: agents of bacterial evolution
Mazel, D. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1462 · Cited by 1,107
A standard numbering scheme for the class A β-lactamases
Ambler, R. P., Coulson, A. F. W., Frère, J. M., Ghuysen, J. M., Joris, B., Forsman, M., Levesque, R. C., Tiraby, G., & Waley, S. G. (1991) · Biochemical Journal · doi:10.1042/bj2760269 · Cited by 1,073
CTX-M Enzymes: Origin and Diffusion
Cantón, R., González-Alba, J. M., & Galán, J. C. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00110 · Cited by 974
Efflux-Mediated Drug Resistance in Bacteria: An Update
Li, X.-Z., & Nikaido, H. (2009) · Drugs · doi:10.2165/11317030-000000000-00000 · Cited by 966
Jacoby, G. A., & Munoz-Price, L. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041359 · Cited by 787
Coque, T. M., Novais, Â., Carattoli, A., Poirel, L., Pitout, J., Peixe, L., Baquero, F., Cantón, R., & Nordmann, P. (2008) · Emerging Infectious Diseases · doi:10.3201/eid1402.070350 · Cited by 702
Penicillin-binding proteins and β-lactam resistance
Zapun, A., Contreras-Martel, C., & Vernet, T. (2008) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2007.00095.x · Cited by 687
Prevalence and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae in Europe
Cantón, R., Novais, A., Valverde, A., Machado, E., Peixe, L., Baquero, F., & Coque, T. M. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2007.01850.x · Cited by 599
Toxins-Antitoxins: Plasmid Maintenance, Programmed Cell Death, and Cell Cycle Arrest
Hayes, F. (2003) · Science · doi:10.1126/science.1088157 · Cited by 583
Factors impacting on the problem of antibiotic resistance
Levy, S. B. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.1.25 · Cited by 547
An enzyme from bacteria able to destroy penicillin. 1940.
Abraham, E. P., & Chain, E. B. (1988) · PubMed · Cited by 532
Bradford, P. A., Urban, C., Mariano, N., Projan, S. J., Rahal, J. J., & Bush, K. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.3.563 · Cited by 450
Evolution and spread of antibiotic resistance
Normark, B. H., & Normark, S. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.01026.x · Cited by 440
CTX-M-type β-lactamases: A successful story of antibiotic resistance
D’Andrea, M. M., Arena, F., Pallecchi, L., & Rossolini, G. M. (2013) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2013.02.008 · Cited by 429
Kinship and Diversification of Bacterial Penicillin-Binding Proteins and β-Lactamases
Massova, I., & Mobashery, S. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.1.1 · Cited by 422
Jaurin, B., & Grundström, T. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.8.4897 · Cited by 390
Pitout, J. D. D. (2010) · Drugs · doi:10.2165/11533040-000000000-00000 · Cited by 376
Rice, L. B., Willey, S. H., Papanicolaou, G. A., Medeiros, A. A., Eliopoulos, G. M., Moellering, R. C., & Jacoby, G. A. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.11.2193 · Cited by 376
Karim, A., Poirel, L., Nagarajan, S., & Nordmann, P. (2001) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2001.tb10762.x · Cited by 359
Epidemiology and genetics of CTX-M extended-spectrum β-lactamases in Gram-negative bacteria
Zhao, W.-H., & Hu, Z.-Q. (2013) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2012.691460 · Cited by 302
Niche heterogeneity in the bone marrow
Birbrair, A., & Frenette, P. S. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13016 · Cited by 282
Antibiotic Resistance: Consequences of Inaction
Levy, S. B. (2001) · Clinical Infectious Diseases · doi:10.1086/321837 · Cited by 257
The CTX-M Conundrum: Dissemination of Plasmids and Escherichia coli Clones
Naseer, U., & Sundsfjord, A. (2011) · Microbial Drug Resistance · doi:10.1089/mdr.2010.0132 · Cited by 236
Geisinger, E., & Isberg, R. R. (2017) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw402 · Cited by 197
Cephalosporinase and penicillinase activities of a β-lactamase from Pseudomonas pyocyanea
Sabath, L., Jago, M., & Abraham, E. (1965) · Biochemical Journal · doi:10.1042/bj0960739 · Cited by 190
Yagi, T., Kurokawa, H., Shibata, N., Shibayama, K., & Arakawa, Y. (2000) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2000.tb08989.x · Cited by 188
The use and resistance to antibiotics in the community
Čižman, M. (2003) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(02)00394-1 · Cited by 188
Extended broad spectrum β-lactamase in Klebsiella pneumoniae including resistance to cephamycins
Bauernfeind, A., Schweighart, S., & Chong, Y. (1989) · Infection · doi:10.1007/bf01650718 · Cited by 182
Bauernfeind, A., Stemplinger, I., Jungwirth, R., & Giamarellou, H. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.1.221 · Cited by 174
Getting to the route of Helicobacter pylori treatment
Goddard, A. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/42.1.1 · Cited by 172
Wright, A. J. (1999) · Mayo Clinic Proceedings · doi:10.4065/74.3.290 · Cited by 167
Hirakata, Y., Matsuda, J., Miyazaki, Y., Kamihira, S., Kawakami, S., Miyazawa, Y., Ono, Y., Nakazaki, N., Hirata, Y., Inoue, M., et al. (2005) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2005.04.004 · Cited by 154
Peirano, G., van der Bij, A. K., Gregson, D. B., & Pitout, J. D. D. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.06025-11 · Cited by 153
Type V secretion: From biogenesis to biotechnology
van Ulsen, P., Rahman, S. U., Jong, W. S. P., Daleke, M. H., & Luirink, J. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.11.006 · Cited by 146
Ryoo, N. H., Kim, E. C., Chong, Y., Park, Y. J., Lee, K., Bae, I. K., Song, E. H., & Jeong, S. H. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki324 · Cited by 144
Ali, T., Rahman, S. U., Zhang, L., Shahid, M. S., Zhang, S., Liu, G., Gao, J., & Han, B. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01931 · Cited by 139
Self-citationSenok, A. C., Khanfar, H. S., Bindayna, K. M., & Botta, G. A. (2009) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.127 · Cited by 138
Queenan, A. M., Foleno, B. D., Gownley, C., Wira, E., & Bush, K. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.1.269-275.2004 · Cited by 128
Bauernfeind, A., Schneider, I., Jungwirth, R., Sahly, H., & Ullmann, U. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.8.1924 · Cited by 124
Oliver, A., Pérez-Díaz, J. C., Coque, T. M., Baquero, F., & Cantón, R. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.616-620.2001 · Cited by 120
Leiza, M. G., Pérez-Díaz, J. C., Ayala, J. A., Casellas, J. M., Martínez-Beltrán, J., Bush, K., & Baquero, F. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.9.2150 · Cited by 111
Klebsiella pneumoniae in Singapore: Hypervirulent Infections and the Carbapenemase Threat
Chew, K. L., Lin, R. T. P., & Teo, J. W. P. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00515 · Cited by 92
First description of CTX-M β-lactamase-producing clinical Escherichia coli isolates from Egypt
Al-Agamy, M. H., Ashour, M. S. E.-D., & Wiegand, I. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.01.007 · Cited by 79
Tawfik, A. F., Al-Swailem, A. M., Shibl, A. M., & Al-Agamy, M. H. (2011) · Microbial Drug Resistance · doi:10.1089/mdr.2011.0011 · Cited by 75
Steward, C. D., Wallace, D., Hubert, S. K., Lawton, R. M., Fridkin, S. K., Gaynes, R. P., McGowan, J. E., & Tenover, F. C. (2000) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(00)00161-9 · Cited by 70
Mathai, D. C., Rhomberg, P. R., Biedenbach, D. J., & Jones, R. N. (2002) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(02)00466-2 · Cited by 69
Rasmussen, B. A., Keeney, D. R., Yang, Y., & Bush, K. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.9.2078 · Cited by 69
Crystal structure of a cold‐adapted class C β‐lactamase
Michaux, C., Massant, J., Kerff, F., Frère, J., Docquier, J., Vandenberghe, I. H. M., Samyn, B., Pierrard, A., Feller, G., Charlier, P., et al. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06324.x · Cited by 63
Tan, G., Peng, Y., Lu, C., Bai, L., & Zhong, J. (2014) · Metabolic Engineering · doi:10.1016/j.ymben.2014.12.003 · Cited by 62
Tamang, M. D., Nam, H.-M., Gurung, M., Jang, G.-C., Kim, S.-R., Jung, S.-C., Park, Y. H., & Lim, S. (2013) · Applied and Environmental Microbiology · doi:10.1128/aem.00522-13 · Cited by 51
Rottman, M., Benzerara, Y., Berçot, B., Bizet, C., Philippon, A., & Arlet, G. (2002) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2002.tb11164.x · Cited by 51
Nucleotide sequence of the ampC-ampR region from the chromosome of Yersinia enterocolitica
Seoane, A., Francia, M. V., & Lobo, J. M. G. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.5.1049 · Cited by 49
Alsterlund, R., Carlsson, B., Gezelius, L., Hæggman, S., & Olsson-Liljequist, B. (2009) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540902896079 · Cited by 43
Fosse, T., Giraud-Morin, C., Madinier, I. M., & Labia, R. (2003) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(03)00253-2 · Cited by 41
Girlich, D., Naas, T., Bellais, S., Poirel, L., Karim, A., & Nordmann, P. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.11.3220-3223.2000 · Cited by 36
Sequence of the MIR-1 β-Lactamase Gene
Jacoby, G. A., & Tran, J. H. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1759 · Cited by 33
Rahman, S. U., Arenas, J., Öztürk, H., Dekker, N., & van Ulsen, P. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.544627 · Cited by 24
Perilli, M., Segatore, B., Mugnaioli, C., Celenza, G., Rossolini, G. M., Stefani, S., Luzzaro, F., Pini, B., & Amicosante, G. (2011) · Microbial Drug Resistance · doi:10.1089/mdr.2011.0059 · Cited by 22
Production of validamycin A from hemicellulose hydrolysate by Streptomyces hygroscopicus 5008
Zhou, T., & Zhong, J. (2014) · Bioresource Technology · doi:10.1016/j.biortech.2014.10.051 · Cited by 20
Clonal expansion of sulfonamide resistant Escherichia coli isolates recovered from diarrheic calves.
Adnan, M., Khan, H., Kashif, J., Ahmad, S., Gohar, A., Ali, A., Khan, M. A., Shah, S., hassan, M. F., Irshad, M., et al. (2017) · Pakistan Veterinary Journal · Cited by 11
Self-citationPiet, J. R., van Ulsen, P., Rahman, S. U., Man-Bovenkerk, S., Bentley, S. D., van de Beek, D., & ENDE, A. V. D. (2016) · Infection and Immunity · doi:10.1128/iai.00160-16 · Cited by 8
Salmonella enterica serovar Enteritidis producing a TEM-52 β-lactamase: first report in Spain
Vázquez, M. F., Bellido, J. L. M., García, M. I. G., & Garcı́a-Rodrı́guez, J. Á. (2006) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2006.01.020 · Cited by 7
Cited by
Molecular mechanisms of antibiotic resistance revisited
Darby, E. M., Trampari, E., Siasat, P., Gaya, M. S., Alav, I., Webber, M. A., & Blair, J. M. A. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00820-y · Cited by 1,398
Extended-Spectrum β-Lactamases (ESBL): Challenges and Opportunities
Husna, A., Rahman, M. M., Badruzzaman, A. T. M., Sikder, M. H., Islam, M. R., Rahman, M. T., Alam, J., & Ashour, H. M. (2023) · Biomedicines · doi:10.3390/biomedicines11112937 · Cited by 337
Exploring phytochemicals for combating antibiotic resistance in microbial pathogens
Khare, T., Anand, U., Dey, A., Assaraf, Y. G., Chen, Z.-S., Liu, Z., & Kumar, V. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.720726 · Cited by 281
“The Plectranthus amboinicus EOs also displayed striking biofilm inhibitory activities against antibiotic resistant S. aureus (Vasconcelos et al., 2017).”
BackgroundFerreira, R. L., da Silva, B. C. M., Rezende, G. S., Nakamura-Silva, R., Pitondo-Silva, A., Campanini, E. B., Brito, M. C. A., da Silva, E. M. L., Freire, C. C. D. M., Cunha, A. F. D., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.03198 · Cited by 257
Metadata
- Authors
- ur Rahman, S., Ali, T., Ali, I., Khan, N. A., Han, B., & Gao, J.
- Venue
- BioMed Research International
- Publisher
- Wiley
- Published
- 2018
- Volume
- 2018
- Pages
- 1-14
- ISSN
- 1110-7243 (ISSN-L)
- 2314-6133
- 2314-6141
- OpenAlex
- W2789345104
- Cited by
- 283
- References
- 68
- FWCI
- 11.70
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.